国际流行病学传染病学杂志
國際流行病學傳染病學雜誌
국제류행병학전염병학잡지
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY AND INFECTIOUS DISEASE
2012年
3期
145-147
,共3页
陈念良%忻亚娟%马景臣%吴洁%金巧军%庄昉成
陳唸良%忻亞娟%馬景臣%吳潔%金巧軍%莊昉成
진념량%흔아연%마경신%오길%금교군%장방성
疫苗%甲型肝炎%安全性%免疫原性
疫苗%甲型肝炎%安全性%免疫原性
역묘%갑형간염%안전성%면역원성
Vaccines%Hepatitis A%Safety%Immunogenicity
目的 观察采用不含明胶、不含人血白蛋白保护剂制备的冻干甲型肝炎(甲肝)减毒活疫苗接种后的安全性及免疫原性.方法 在浙江杭州及河北正定二个点,筛选了183名甲肝病毒易感者,给予冻干甲肝减毒活疫苗一针免疫.观察疫苗接种后7d内的局部和全身反应,同时采集接种后的血清样本,检测甲肝抗体阳转率及抗体产生的水平.结果 观察期间主要表现为轻度反应,肝功能检测未见异常,未发生与疫苗有关的重度反应、皮疹及不良事件.疫苗接种后2个月的抗体阳转率为98.2%,抗体的几何平均滴度为135.5 mIU/mL.结论 不含明胶、不含人血白蛋白的保护剂制备的疫苗安全性及免疫原性良好.
目的 觀察採用不含明膠、不含人血白蛋白保護劑製備的凍榦甲型肝炎(甲肝)減毒活疫苗接種後的安全性及免疫原性.方法 在浙江杭州及河北正定二箇點,篩選瞭183名甲肝病毒易感者,給予凍榦甲肝減毒活疫苗一針免疫.觀察疫苗接種後7d內的跼部和全身反應,同時採集接種後的血清樣本,檢測甲肝抗體暘轉率及抗體產生的水平.結果 觀察期間主要錶現為輕度反應,肝功能檢測未見異常,未髮生與疫苗有關的重度反應、皮疹及不良事件.疫苗接種後2箇月的抗體暘轉率為98.2%,抗體的幾何平均滴度為135.5 mIU/mL.結論 不含明膠、不含人血白蛋白的保護劑製備的疫苗安全性及免疫原性良好.
목적 관찰채용불함명효、불함인혈백단백보호제제비적동간갑형간염(갑간)감독활역묘접충후적안전성급면역원성.방법 재절강항주급하북정정이개점,사선료183명갑간병독역감자,급여동간갑간감독활역묘일침면역.관찰역묘접충후7d내적국부화전신반응,동시채집접충후적혈청양본,검측갑간항체양전솔급항체산생적수평.결과 관찰기간주요표현위경도반응,간공능검측미견이상,미발생여역묘유관적중도반응、피진급불량사건.역묘접충후2개월적항체양전솔위98.2%,항체적궤하평균적도위135.5 mIU/mL.결론 불함명효、불함인혈백단백적보호제제비적역묘안전성급면역원성량호.
Objective To observe the safety and immunogenicity of freeze-dried live attenuated hepatitis A vaccine prepared by a protective additive without gelatin and human albumin.Methods One hundred and eighty-three persons susceptible to hepatitis A virus were screened from 2 sites in Hangzhou,Zhejiang and Zhengding,Hebei.Each person was inoculated by one dose live attenuated hepatitis A vaccine and observed for local and systemic reaction in 7 days.Serum samples were collected after vaccination for determining the seroconversion rates and antibody levels.Results Most of the reactions were mild in period of observation,and there were no abnormal liver function and severe reactions such as rashes,adverse events related with the vaccine.The seroconversion rate was 98.2% after 2 months of vaccination,the geometric mean titer of anti-HAV was 135.5 mIU/mL.Conclusions The study indicates that freeze-dried live attenuated hepatitis A vaccine without gelatin and human albumin is safe and has a good immunogenicity.